Showing results (251-260 of 328) with videos related to

Sort By:
Pageof 33
Nuclear Medicine Communications|June 8, 2015
Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphyVarun S Dhull, Punit Sharma, Chetan Patel, et al.
European Radiology|October 6, 2011
Prospective evaluation of ⁶⁸Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma: preliminary results from a single centre studyNiraj Naswa, Punit Sharma, Aftab Hasan Nazar, et al.
Neuroradiology|July 4, 2014
Perfusion-metabolism coupling in recurrent gliomas: a prospective validation study with 13N-ammonia and 18F-fluorodeoxyglucose PET/CTBangkim Chandra Khangembam, Sellam Karunanithi, Punit Sharma, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Comparative Evaluation of [68Ga]Ga-DOTA.SA.FAPi and [18F]FDG PET/CT in Metastatic Breast and Lung Cancer: Semiquantitative, Volumetric and Prognostic AssessmentSulochana Sarswat, Sanjana Ballal, Madhav Prasad Yadav, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2023
Long-term survival outcomes of salvage [<sup>225</sup>Ac]Ac-PSMA-617 targeted alpha therapy in patients with PSMA-expressing end-stage metastatic castration-resistant prostate cancer: a real-world studySanjana Ballal, Madhav P Yadav, Swayamjeet Satapathy, et al.
European Journal of Radiology|November 7, 2013
Can (18)F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective studySellam Karunanithi, Punit Sharma, Abhishek Kumar, et al.
Diagnostic and Interventional Radiology (Ankara, Turkey)|June 11, 2013
SPECT-CT for characterization of extraosseous uptake of 99mTc-methylene diphosphonate on bone scintigraphyRamya Soundararajan, Niraj Naswa, Punit Sharma, et al.
Clinical Nuclear Medicine|October 25, 2013
Predictive value of 68Ga-DOTANOC PET/CT in patients with suspicion of neuroendocrine tumors: is its routine use justified?Punit Sharma, Saurabh Arora, Anirban Mukherjee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 22, 2025
Clinical Outcomes of <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World ExperienceKunal Ramesh Chandekar, Swayamjeet Satapathy, Sanjana Ballal, et al.
Nuclear Medicine Communications|April 14, 2021
F-18 ML-104 tau PET imaging in mild cognitive impairmentJasim Jaleel, Madhavi Tripathi, Vivek Baghel, et al.
Pageof 33